Dubai’s 691,478 medical tourists put DHA providers in the 2026 GCC race

Dubai attracted 691,478 medical tourists in 2023, making patient acquisition, audited quality and digital intake the operating test for DHA-regulated providers before the 2026 GCC medical tourism push.

The executive takeaway is clear: Dubai already has the volume benchmark, but higher-margin growth will depend on whether hospitals can prove outcomes, convert overseas inquiries faster and package specialty care with regulator-ready workflows.

Dubai’s benchmark is already public

Travel And Tour World placed Dubai alongside Riyadh, Doha, Muscat, Manama and Kuwait City as GCC cities compete for medical tourists in 2026. The more important local baseline came from the Government of Dubai Media Office, which reported 691,478 medical tourists and direct healthcare spending above AED 1.034 billion in 2023.

The 2023 total rose from 674,000 patients in 2022, while direct spending increased from AED 992 million. The Government of Dubai Media Office also reported indirect revenue above AED 2.305 billion in 2023, a reminder that hospital groups are competing inside a wider chain of hotels, aviation links, concierge partners and follow-up services.

• 691,478 medical tourists visited Dubai in 2023, according to the Government of Dubai Media Office.
• Direct healthcare spending exceeded AED 1.034 billion in 2023, up from AED 992 million in 2022.
• Indirect revenue exceeded AED 2.305 billion in 2023.
• The implied direct healthcare spend was about AED 1,495 per medical tourist in 2023.

Regulation is now part of patient acquisition

For Dubai operators, the relevant regulator is the Dubai Health Authority (DHA). DHA’s Dubai Health Experience, or DXH, gives hospitals and clinics a formal route into the emirate’s medical tourism programme. DHA lists DXH group membership for hospitals, clinics and other facilities, with service availability of 24 hours, 7 days and no fee shown on the current service page.

Abu Dhabi gives providers a useful comparison point. The Department of Health Abu Dhabi (DoH) medical tourism standard requires participating providers to meet minimum conditions, including international accreditation and complaint procedures before, during and after treatment. DoH also requires facilities to periodically report tourists receiving treatment.

DoH reporting rules bring the compliance issue closer to revenue operations. DoH’s Shafafiya materials include medical tourism, self-pay and non-insurance claim reporting, with an updated medical tourism definition dated 17 October 2022 and updated reporting requirements dated 3 June 2024. Dubai providers use a different regulatory stack, but the same operational question applies: can intake, consent, billing and follow-up be traced without slowing the patient journey?

Specialty depth will decide yield

Travel And Tour World cited AI healthcare and neuro-regenerative care in its 2026 GCC framing. For UAE hospitals, those themes need to become specific service lines with named clinicians, outcomes data, payer clarity and post-discharge protocols. Broad destination marketing will be weaker than a measurable pathway for neurology, orthopaedics, fertility, oncology or advanced diagnostics.

For CFOs, the number to remember is AED 1,495 of direct healthcare spend per medical tourist in 2023. That average includes lower-acuity activity, so hospitals pursuing higher-value specialties should track international patient revenue separately from local self-pay and routine outpatient visits.

The next signal is whether DHA publishes post-2023 medical tourist volumes or specialty-level revenue. If Dubai raises yield through higher-acuity care in 2026, providers with international accreditation, referral partnerships and multilingual case management will have the clearer pricing case.